Stimulating discussion: neuromodulation for migraine in pregnancy
Neuromodulation may already represent a clinically meaningful nonpharmacologic alternative for treating migraine during pregnancy. Neuromodulation offers precision therapy, clinical data tracking, and the potential to treat multiple pregnancy health conditions. Despite its safety potential, it remains underutilized. Increased research, clinician education, and multidisciplinary care could support broader adoption.
Authors
- Jolene Seibel-Seamon
- Gregory A. Panza (ORCID: https://orcid.org/0000-0003-1411-3148)
- Deena E. Kuruvilla (ORCID: https://orcid.org/0000-0002-1997-5663)
- Michael A.L. Johnson
- Michele Godorecci
Institutions
- Hartford Hospital (US)
- Allen Institute for Brain Science (US)
- Virtua Voorhees Hospital (US)
- Virtua Health (US)
- Haute École de Namur-Liège-Luxembourg (BE)
- Dermatology Specialists (US)
Publication Details
- Journal
- Current Opinion in Obstetrics & Gynecology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1097/gco.0000000000001075
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00